Kelly J Gaffney

8PUBLICATIONS
7CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)Technology, crime and surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 03, 2024
Impact of age, obesity, and renal impairment on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma.

Kelly J Gaffney, Jonathan K Bakos, Arash Velayati

|Apr 25, 2023
Early versus standard management of chimeric antigen receptor therapy toxicities and management's impact on safety and efficacy.

Kelly J Gaffney, James A Davis, Mary McGann

|Feb 13, 2023
Newly approved and forthcoming T-cell-redirecting bispecific antibodies for the treatment of relapsed/refractory multiple myeloma.

Katelynn Granger, Kelly J Gaffney, James A Davis

|Feb 04, 2023
Prophylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment Period.

Kelly J Gaffney, Theresa A Urban, Mariana Lucena

|Jan 19, 2023
The incidence and characteristics of VTE within 100 days of CAR T-cell therapy.

Kelly J Gaffney, Mary McGann, James A Davis

|Nov 04, 2022
Efficacy of tixagevimab-cilgavimab in preventing SARS-CoV-2 for patients with B-cell malignancies.

James A Davis, Katelynn Granger, Kiera Roubal

Pageof 2

Frequent Collaborators

5 joint publications

James A Davis

4 joint publications

Hamza Hashmi

1 joint publications

Robert M Dean

1 joint publications

Abigail Shockley